These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 20507192

  • 1. Compassionate use of intravitreal pegaptanib in patients with age-related macular degeneration.
    Ricci F, Missiroli F, Cedrone C, Grossi M, Regine F.
    Semin Ophthalmol; 2010; 25(1-2):16-20. PubMed ID: 20507192
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.
    Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN.
    Am J Ophthalmol; 2006 Jul; 142(1):1-9. PubMed ID: 16815245
    [Abstract] [Full Text] [Related]

  • 4. RPE tears after pegaptanib treatment in age-related macular degeneration.
    Chang LK, Flaxel CJ, Lauer AK, Sarraf D.
    Retina; 2007 Sep; 27(7):857-63. PubMed ID: 17891009
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pegaptanib for choroidal neovascularization in treatment-naïve exudative age-related macular degeneration.
    Ehlers JP, Fintak DR, Gupta OP, Regillo CD, Fineman MS, Ho AC.
    Ophthalmic Surg Lasers Imaging; 2007 Sep; 38(5):371-7. PubMed ID: 17955841
    [Abstract] [Full Text] [Related]

  • 10. A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.
    Algvere PV, Steén B, Seregard S, Kvanta A.
    Acta Ophthalmol; 2008 Aug; 86(5):482-9. PubMed ID: 18162062
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Standardized visual acuity results associated with primary versus secondary bevacizumab (avastin) treatment for choroidal neovascularization in age-related macular degeneration.
    Falkenstein IA, Cheng L, Morrison VL, Kozak I, Tammewar AM, Freeman WR.
    Retina; 2007 Aug; 27(6):701-6. PubMed ID: 17621178
    [Abstract] [Full Text] [Related]

  • 17. Pegaptanib sodium for occult choroidal neovascularization in neovascular age-related macular degeneration: a prospective case series.
    Atmani K, Coscas F, Coscas G, Soubrane G.
    Eye (Lond); 2009 May; 23(5):1150-4. PubMed ID: 18636083
    [Abstract] [Full Text] [Related]

  • 18. Treatment of choroidal neovascularization using intravitreal bevacizumab.
    Pedersen R, Soliman W, Lund-Andersen H, Larsen M.
    Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
    [Abstract] [Full Text] [Related]

  • 19. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Arias L, Ruiz-Moreno JM, Gómez-Ulla F, Fernández M, Montero J.
    Retina; 2009 Aug; 29(10):1444-9. PubMed ID: 19730163
    [Abstract] [Full Text] [Related]

  • 20. Combined Pegaptanib sodium (Macugen) and photodynamic therapy in predominantly classic juxtafoveal choroidal neovascularisation in age related macular degeneration.
    Calvo-González C, Reche-Frutos J, Donate-López J, García-Feijoó J, Leila M, Fernández-Pérez C, Garcia-Sánchez J.
    Br J Ophthalmol; 2008 Jan; 92(1):74-5. PubMed ID: 18156376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.